Skip to content

Alkermes Plc

ALKS

Latest QuantConomy context for ALKS: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
20
Asset profile

Alkermes Plc

QuantConomy has a structured record for ALKS. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
ALKS
Name
Alkermes Plc
Coverage
3 market/data records
Sources
alphavantage fmp alpaca sec nasdaq openfigi
Latest signal rows

Recent signals for ALKS

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
major spike
neutral
69
Jul 10, 05:34 PM ALKS major volume spike: 1026% of expected volume for Friday 17:00 UTC, price flat 0.06% (strength 69)
volume spike
neutral
41
Jul 10, 04:39 PM ALKS volume spike: 396% of expected volume for Friday 16:00 UTC, price flat 0.10% (strength 41)
volume spike
neutral
38
Jul 10, 03:59 PM ALKS volume spike: 303% of expected volume for Friday 15:00 UTC, price flat 0.22% (strength 38)

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market coverage

Market Exchange Source Asset record
ALKS NASDAQ alphavantage Alkermes plc
ALKS NASDAQ fmp Alkermes plc
ALKS NASDAQ alpaca Alkermes plc Ordinary Shares

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
4
Rows
20
Date Insider Role Type Shares Price Value Filing
Jul 6, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. sale 2,034 $54.03 $109,897 4 on EDGAR
Jul 1, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer exercise 5,000 $19.34 $96,700 4 on EDGAR
Jun 12, 2026 Wright Christopher I Insider sale 2,000 $45.10 $90,200 4 on EDGAR
Jun 4, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. sale 2,034 $43.05 $87,564 4 on EDGAR
Jun 1, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer exercise 5,000 $19.34 $96,700 4 on EDGAR
May 29, 2026 Parisi Samuel Joseph VP, Finance (Interim PAO) exercise 3,392 $20.03 $67,942 4 on EDGAR
May 21, 2026 LAURENCIN CATO T Insider exercise 6,142 4 on EDGAR
May 21, 2026 snyderman nancy lynn MD Insider exercise 6,142 4 on EDGAR
May 21, 2026 Wright Christopher I Insider exercise 6,142 4 on EDGAR
May 21, 2026 Lurker Nancy Insider exercise 6,142 4 on EDGAR
May 21, 2026 Cooke Shane Insider exercise 6,142 4 on EDGAR
May 20, 2026 GAYNOR RICHARD Insider grant 11,538 4 on EDGAR
May 21, 2026 GAYNOR RICHARD Insider exercise 6,142 4 on EDGAR
May 21, 2026 MCKEON BRIAN P Insider exercise 6,142 4 on EDGAR
May 21, 2026 Wilson Frank Anders Insider exercise 6,142 4 on EDGAR
May 20, 2026 Cooke Shane Insider grant 11,538 4 on EDGAR
May 4, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. sale 2,034 $33.20 $67,529 4 on EDGAR
May 1, 2026 Hopkinson Craig C. EVP R&D, Chief Medical Officer exercise 5,000 $19.34 $96,700 4 on EDGAR
Apr 11, 2026 Lurker Nancy Insider exercise 3,751 4 on EDGAR
Apr 6, 2026 Gaffin David Joseph EVP, CLO, Alkermes, Inc. sale 2,034 $34.57 $70,315 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query ALKS context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access